https://www.selleckchem.com/pr....oducts/way-309236-a.
06). Those who received concurrent chemotherapy had better survival than those with radiotherapy alone. 40% patients developed grade III IV dermatitis and 48% patients developed grade III oral mucositis. Chemoradiotherapy can safely be offered to patients with synchronous esophageal and head and neck cancer. Chemoradiotherapy can safely be offered to patients with synchronous esophageal and head and neck cancer. Survivors with head and neck cancer (HNC) report cancer-related fatigue (CRF) as a devastating, prevalent health is
Like
Comment
Share
